Skip to main content
Figure 1 | BMC Infectious Diseases

Figure 1

From: Long-term outcomes after nucleos(t)ide analogues discontinuation in chronic hepatitis B patients with HBeAg-negative

Figure 1

Survival functions for the cumulative rate of sustained response and the time of sustained response after NUCs discontinuation. The cumulative rate of sustained response was 71.2% (A). No significant difference in the cumulative rate of sustained response was seen by sex (B, P=0.523), age group (C, P=0.445), genotype (D, P=0.322), or baseline ALT group (E, P=0.294).

Back to article page
\